0000899243-18-028231.txt : 20181105 0000899243-18-028231.hdr.sgml : 20181105 20181105180405 ACCESSION NUMBER: 0000899243-18-028231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181105 FILED AS OF DATE: 20181105 DATE AS OF CHANGE: 20181105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vollins James CENTRAL INDEX KEY: 0001757833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 181161007 MAIL ADDRESS: STREET 1: C/O BIODELIVERY SCIENCES INTERNATIONAL STREET 2: 4131 PARK LAKE AVE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-05 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001757833 Vollins James C/O BIODELIVERY SCIENCES INTL, INC. 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 0 1 0 0 See Remarks Stock Options (right to buy) 3.46 2018-11-05 4 A 0 89476 0.00 A 2028-11-05 Common Stock 89476 89476 D The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Company's Common Stock for the 30-day period preceding November 5, 2018. The stock options were issued to the Reporting Person on November 5, 2018, pursuant to a grant under the Company's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal portions on: (i) November 5, 2019; (ii) November 5, 2020; and (iii) November 5, 2021. General Counsel, Chief Compliance Officer & Corporate Secretary /s/ James Vollins 2018-11-05